NCT00001991View on ClinicalTrials.gov

A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Pneumonia, Pneumocystis CariniiHIV Infections
Interventions
DRUG

Atovaquone

Trial Locations (1)

27709

Glaxo Wellcome Inc, Research Triangle Park

Sponsors

Lead Sponsor

Glaxo Wellcome
All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY

NCT00001991 - A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia | Biotech Hunter | Biotech Hunter